135 related articles for article (PubMed ID: 17890905)
1. p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas.
Sarek G; Ojala PM
Cell Cycle; 2007 Sep; 6(18):2205-9. PubMed ID: 17890905
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM
J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023
[TBL] [Abstract][Full Text] [Related]
3. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
[TBL] [Abstract][Full Text] [Related]
5. Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma.
Dai L; Cao Y; Chen Y; Parsons C; Qin Z
J Hematol Oncol; 2014 Apr; 7():30. PubMed ID: 24708874
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
[TBL] [Abstract][Full Text] [Related]
7. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.
Sarek G; Järviluoma A; Ojala PM
Blood; 2006 Jan; 107(2):725-32. PubMed ID: 16160006
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
9. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.
Gloghini A; Dolcetti R; Carbone A
Semin Cancer Biol; 2013 Dec; 23(6):457-67. PubMed ID: 23999127
[TBL] [Abstract][Full Text] [Related]
10. Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies.
Noguchi K; Fukazawa H; Murakami Y; Takahashi N; Yamagoe S; Uehara Y
Cancer Sci; 2007 Sep; 98(9):1288-96. PubMed ID: 17640300
[TBL] [Abstract][Full Text] [Related]
11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
12. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
[TBL] [Abstract][Full Text] [Related]
13. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
14. Etiology of AIDS-related Kaposi's sarcoma and lymphoma.
Boshoff C; Whitby D; Talbot S; Weiss RA
Oral Dis; 1997 May; 3 Suppl 1():S129-32. PubMed ID: 9456674
[TBL] [Abstract][Full Text] [Related]
15. AIDS-related lymphomas: from pathogenesis to pathology.
Carbone A; Gloghini A
Br J Haematol; 2005 Sep; 130(5):662-70. PubMed ID: 16115121
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
[TBL] [Abstract][Full Text] [Related]
17. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
18. KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas.
Järviluoma A; Koopal S; Räsänen S; Mäkelä TP; Ojala PM
Blood; 2004 Nov; 104(10):3349-54. PubMed ID: 15271792
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.
Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A
Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356
[TBL] [Abstract][Full Text] [Related]
20. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
